GlassScriptPhysician profile
Olivia Wang Galloway
NPI 1497217806
$1,663.66
in general payments reported to CMS, 2019-2025
11 companies · $1,328 in 2025
The $1,328 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $60.32 · 2024: $276 · 2025: $1,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $857 · Food and Beverage: $807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $856.51 |
| Food and Beverage | $807.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $643.19 | 2025 | Gelpoint Advanced Access Platform, Gelport Laparoscopic System |
| Elucent Medical | $484.38 | 2025 | |
| Leica Microsystems INC. | $161.00 | 2025 | Mammotome Elite |
| Endomagnetics LTD | $127.50 | 2024 | Magtrace, Magseed |
| Endologix LLC | $81.69 | 2024 | Torus Stent Graft System, Endocross Device |
| Medtronic, INC. | $38.45 | 2024 | V-Loc 180 |
| Takeda Pharmaceuticals U.S.A., INC. | $30.88 | 2023 | Gattex |
| Mozarc Medical US LLC | $29.44 | 2023 | Palindrome |
| Solventum Corporation | $27.92 | 2024 | Prevena, V.A.C. Veraflo |
| Pacira Pharmaceuticals Incorporated | $24.44 | 2025 | Exparel |
| Tela Bio, INC. | $14.77 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Galloway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.